Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In Vitro Maturation (IVM) with or without hCG priming in infertile women with polycystic ovaries
2006-000194-29Phase 4Completed
- Sponsor
- Oxford University Hospitals
- Start
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of recombinant human chorionic gonadotrophin in infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Oxford University Hospitals. Primary endpoint: Completed 9 weeks pregnancy. Started Mar 2006; status: completed.
02
Drugs
recombinant human chorionic gonadotrophin
03
Conditions
infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2006-000194-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000194-29.